Navigation Links
Duragesic Trials Continue - Plaintiffs Optimistic After Latest Recall
Date:2/13/2008

Lawyer who brought the first federal case against J&J prepares for next

trial

LOS ANGELES, Feb. 13 /PRNewswire/ -- In the wake of Tuesday's Duragesic recall of over 2 million patches, lawyer Ike Gulas prepares to take the next major case against pharmaceutical giant Johnson and Johnson to trial in California State Court Southeast District in Los Angeles.

The Birmingham, Ala.-based law firm Gulas & Stuckey PC took the first Duragesic case to federal trial in West Palm Beach in June 2007, winning a $5.5 million verdict for the family of Adam Hendelson who died from an overdose of the drug fentanyl when the patch he wore due to chronic hip pain leaked.

The family of Carol Pinedo will be the second of Gulas & Stuckey's clients to face Johnson & Johnson subsidiaries Janssen Pharmaceutica Products, LP, and ALZA Corp. in court over death resulting from the company's pain patch Duragesic.

Pinedo died in April 2004, the same month Janssen issued a recall of about 2.2 million patches after determining that some might leak along one edge. She was 39 at the time and had been wearing a Duragesic patch for 6 months as treatment for severe migraines following the removal of benign brain tumors.

Pinedo's husband Joseph, has brought the suit forward to Gulas & Stuckey after his wife's death. Joseph is a custodian for the Los Angeles school system with four children: Jessie Marie, Michelle, Christine and Natalie Angela.

"The manufacturers of this drug should be held accountable," said Ike Gulas. "This recent recall reaffirms the fact that this drug is lethal and is responsible for many unnecessary deaths, as in the case of Carol Pinedo."

More than 100 cases have been filed nationwide involving Duragesic. Gulas & Stuckey will take the Pinedo case to trial sometime later this year.

For more information about Duragesic and about Gulas & Stuckey, P.C., go to http://www.gulasandstuckey.com/PracticeAreas/duragesic.asp.


'/>"/>
SOURCE Gulas & Stuckey, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
2. Study Questions Dead-End Cancer Clinical Trials
3. Clinical trials present better alternatives for dialysis patients
4. IMPACT initiative looks to improve patient participation in clinical trials
5. Clinical Trials Directive still hampering academic medical research
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. American Pacific Management to Present at CIBC World Markets 2nd Industrials Conference
8. Clinical Trials for Lupus Underway After Decades of Drought
9. Paving the way for future pan-European clinical trials
10. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
11. Rutgers biomaterial debuts in clinical trials of new stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology: